每周股票复盘：三星医疗（601567）Q3净利下降55.22%

Core Points - Samsung Medical (601567) experienced a stock price decline of 2.61% this week, closing at 22.41 yuan, with a market cap of 31.491 billion yuan [1] - The company was listed on the "Dragon and Tiger List" due to a price drop deviation of 7%, marking its first appearance in the last five trading days [2] - As of September 30, 2025, the number of shareholders increased to 33,500, reflecting a growth of 15.72% [3] - The company's Q3 2025 financial report indicated a 6.19% year-on-year increase in revenue to 11.08 billion yuan, but a significant decline in net profit by 15.85% to 1.528 billion yuan [4] Trading Information - Samsung Medical's stock reached a high of 25.39 yuan and a low of 22.02 yuan during the week, with no instances of closing at the daily limit up and one instance of closing at the daily limit down [1] - The company was highlighted in the trading information for having a price drop deviation of 7%, which led to its listing on the "Dragon and Tiger List" [2] Shareholder Changes - The total number of shareholders increased by 4,551, resulting in a 15.72% rise, while the average number of shares held per shareholder decreased from 48,700 to 41,900 [3] Financial Performance - In Q3 2025, Samsung Medical reported a revenue of 3.108 billion yuan, a decrease of 9.56% year-on-year, and a net profit of 298 million yuan, down 55.22% year-on-year [4] - The company's non-recurring net profit fell by 78.54% to 144 million yuan in the same quarter, with a debt ratio of 47.57% and an investment income of 179 million yuan [4]